Glyphosate Coming Under EPA Scrutiny

Fighting a wave of lawsuits filed by Roundup victims, along with mounting governmental investigations into Roundup’s harmful effects – including being a “probable human carcinogen” – could have German chemical giant Bayer second-guessing its hasty takeover strategy.
Meanwhile, in a pattern know to all, military-industrial complex player Monsanto deploys its significant monetary-backed political muscle to silence critics and opponents. Jim

“The German company’s intended $66 billion acquisition of Monsanto Co. comes amid growing concern over the future of the company’s top-selling weed killer, a chemical called glyphosate that Monsanto introduced to the world 40 years ago as the active ingredient in its Roundup herbicide. Monsanto reaps billions of dollars annually, roughly a third of its sales, from those products…

“…Agrichemical interests have gone so far as to tell the EPA that the meetings should not be held at all, and have said that if they are, many of the world’s top scientists should be excluded from participating…

“The EPA’s appearance of aligning with Monsanto angers many in the scientific community who say the EPA is straying from established scientific principles and ignoring key evidence so it can keep the corporate interests who profit from glyphosate herbicides happy

“‘This chemical is a probable human carcinogen by any reasonable definition. It is nonsense to say otherwise,’ said Christopher Portier, former director of the National Center for Environmental Health and Agency for Toxic Substances and Disease Registry at the U.S. Centers for Disease Control and Prevention (CDC). Prior to that role, Portier spent 32 years with the National Institute of Environmental Health Sciences (NIEHS), where he served as the NIEHS associate director, director of the Environmental Toxicology Program, and associate director of the National Toxicology Program.”